FOLH1 and Familial prostate cancer: With this study we aimed to investigate a comprehensive analysis of the downgrading dynamics in patients diagnosed with GS 8 (4+4) prostate cancer via biopsy, specifically focusing on the role of PSMA PET/CT as a primary staging tool to predict downgrading following radical prostatectomy.